vs

Side-by-side financial comparison of Akso Health Group (AHG) and enCore Energy Corp. (EU). Click either name above to swap in a different company.

enCore Energy Corp. is the larger business by last-quarter revenue ($12.4M vs $7.0M, roughly 1.8× Akso Health Group). Akso Health Group runs the higher net margin — -18.6% vs -173.9%, a 155.3% gap on every dollar of revenue.

Akso Health Group is a global healthcare enterprise specializing in the R&D, production, and distribution of generic pharmaceuticals, over-the-counter wellness products, and medical devices. It primarily serves markets in China, Southeast Asia, and North America, with core business segments covering drug manufacturing, medical supply chains, and community healthcare services.

Devon Energy Corporation is an American company engaged in hydrocarbon exploration. It is organized in Delaware with operational headquarters in the 50-story Devon Energy Center in Oklahoma City, Oklahoma. Its operations are in the Delaware Basin, Eagle Ford Group, and the Rocky Mountains.

AHG vs EU — Head-to-Head

Bigger by revenue
EU
EU
1.8× larger
EU
$12.4M
$7.0M
AHG
Higher net margin
AHG
AHG
155.3% more per $
AHG
-18.6%
-173.9%
EU

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
AHG
AHG
EU
EU
Revenue
$7.0M
$12.4M
Net Profit
$-1.3M
$-21.5M
Gross Margin
8.9%
37.9%
Operating Margin
-20.5%
-135.9%
Net Margin
-18.6%
-173.9%
Revenue YoY
Net Profit YoY
EPS (diluted)
$-0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AHG
AHG
EU
EU
Q4 25
$12.4M
Q3 25
$7.0M
$8.9M
Q2 25
$3.7M
Q1 25
$18.2M
Net Profit
AHG
AHG
EU
EU
Q4 25
$-21.5M
Q3 25
$-1.3M
$-4.8M
Q2 25
$-6.3M
Q1 25
$-24.2M
Gross Margin
AHG
AHG
EU
EU
Q4 25
37.9%
Q3 25
8.9%
43.8%
Q2 25
30.8%
Q1 25
-0.1%
Operating Margin
AHG
AHG
EU
EU
Q4 25
-135.9%
Q3 25
-20.5%
-158.2%
Q2 25
-526.1%
Q1 25
-85.7%
Net Margin
AHG
AHG
EU
EU
Q4 25
-173.9%
Q3 25
-18.6%
-53.7%
Q2 25
-172.7%
Q1 25
-132.9%
EPS (diluted)
AHG
AHG
EU
EU
Q4 25
$-0.11
Q3 25
$-0.03
Q2 25
$-0.03
Q1 25
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AHG
AHG
EU
EU
Cash + ST InvestmentsLiquidity on hand
$11.1M
$52.4M
Total DebtLower is stronger
$110.0M
Stockholders' EquityBook value
$198.3M
$229.2M
Total Assets
$212.0M
$430.4M
Debt / EquityLower = less leverage
0.48×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AHG
AHG
EU
EU
Q4 25
$52.4M
Q3 25
$11.1M
$91.9M
Q2 25
$26.9M
Q1 25
$29.7M
Total Debt
AHG
AHG
EU
EU
Q4 25
$110.0M
Q3 25
$109.3M
Q2 25
Q1 25
Stockholders' Equity
AHG
AHG
EU
EU
Q4 25
$229.2M
Q3 25
$198.3M
$248.6M
Q2 25
$264.7M
Q1 25
$267.9M
Total Assets
AHG
AHG
EU
EU
Q4 25
$430.4M
Q3 25
$212.0M
$441.9M
Q2 25
$359.4M
Q1 25
$362.6M
Debt / Equity
AHG
AHG
EU
EU
Q4 25
0.48×
Q3 25
0.44×
Q2 25
Q1 25

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AHG
AHG
EU
EU
Operating Cash FlowLast quarter
$1.2M
$12.9M
Free Cash FlowOCF − Capex
$7.2M
FCF MarginFCF / Revenue
57.8%
Capex IntensityCapex / Revenue
46.7%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-45.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AHG
AHG
EU
EU
Q4 25
$12.9M
Q3 25
$1.2M
$-20.3M
Q2 25
$-9.9M
Q1 25
$-7.7M
Free Cash Flow
AHG
AHG
EU
EU
Q4 25
$7.2M
Q3 25
$-26.3M
Q2 25
$-14.1M
Q1 25
$-11.7M
FCF Margin
AHG
AHG
EU
EU
Q4 25
57.8%
Q3 25
-296.6%
Q2 25
-385.2%
Q1 25
-64.1%
Capex Intensity
AHG
AHG
EU
EU
Q4 25
46.7%
Q3 25
68.0%
Q2 25
115.1%
Q1 25
21.7%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons